Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$54,703 Mln
P/E Ratio
40
P/B Ratio
241.43
Industry P/E
28.89
Debt to Equity
26.2
ROE
1.98 %
ROCE
--
Div. Yield
0.78 %
Book Value
--
EPS
7.03
CFO
$26,795.61 Mln
EBITDA
$17,941.68 Mln
Net Profit
$3,142.60 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| 27.25 | 6.88 | 15.06 | 20.15 | 21.60 | 26.37 | 9.49 |
|
BSE Sensex*
| 2.52 | 3.37 | 6.44 | 8.80 | 12.18 | 20.37 | 11.43 |
|
S&P Midcap 400
| -9.16 | -6.21 | -13.55 | -2.39 | 3.11 | 12.80 | 6.32 |
|
2024
|
2023
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|
|
CoreSite Realty Corporation (COR)
| 9.32 | 23.94 | 40.18 | 16.48 | 34.05 | -20.07 |
|
S&P Midcap 400
| 12.12 | 14.45 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 159.88 | 53,839.43 | 150.83 | 0.29 | |
| 141.05 | 31,253.72 | 35 | 6.03 | |
| 290.91 | 51,535.87 | 27.32 | 21.13 | |
| 68.16 | 29,833.50 | 358.74 | 0.8 |
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and... equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania. Read more
Chairman, President & CEO
Mr. Steven H. Collis
Executive Chairman
Mr. Steven H. Collis
Headquarters
Conshohocken, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of CoreSite Realty Corporation (COR) stood at $ 123,563 Mln as on 31-Dec-24
The share price of CoreSite Realty Corporation (COR) is $285.90 (NYSE) as of 25-Apr-2025 16:00 EDT. CoreSite Realty Corporation (COR) has given a return of 21.6% in the last 3 years.
CoreSite Realty Corporation (COR) has a market capitalisation of $ 54,703 Mln as on 25-Apr-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of CoreSite Realty Corporation (COR) is 241.43 times as on 25-Apr-2025, a 21456% premium to its peers’ median range of 1.12 times.
The P/E ratio of CoreSite Realty Corporation (COR) is 40.00 times as on 25-Apr-2025, a 38% premium to its peers’ median range of 28.89 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the CoreSite Realty Corporation (COR) and enter the required number of quantities and click on buy to purchase the shares of CoreSite Realty Corporation (COR).
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
The CEO & director of Mr. Steven H. Collis. is CoreSite Realty Corporation (COR), and CFO & Sr. VP is Mr. Steven H. Collis.
There is no promoter pledging in CoreSite Realty Corporation (COR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
5,204
|
|
|
5,105
|
|
|
3,143
|
|
|
3,004
|
| CoreSite Realty Corporation (COR) | Ratios |
|---|---|
|
Return on equity(%)
|
240.05
|
|
Operating margin(%)
|
0.68
|
|
Net Margin(%)
|
0.46
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of CoreSite Realty Corporation (COR) was $0 Mln.
$3.51
(
